Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19174497rdf:typepubmed:Citationlld:pubmed
pubmed-article:19174497lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:19174497lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:19174497lifeskim:mentionsumls-concept:C0011860lld:lifeskim
pubmed-article:19174497lifeskim:mentionsumls-concept:C0020615lld:lifeskim
pubmed-article:19174497lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:19174497lifeskim:mentionsumls-concept:C1570906lld:lifeskim
pubmed-article:19174497pubmed:issue4lld:pubmed
pubmed-article:19174497pubmed:dateCreated2009-4-7lld:pubmed
pubmed-article:19174497pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19174497pubmed:abstractTextDipeptidyl peptidase-4 inhibitors act by increasing plasma levels of glucagon-like peptide-1 and suppressing excessive glucagon secretion in patients with type 2 diabetes. However, their effects on the glucagon response to hypoglycemia are not established.lld:pubmed
pubmed-article:19174497pubmed:languageenglld:pubmed
pubmed-article:19174497pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19174497pubmed:citationSubsetAIMlld:pubmed
pubmed-article:19174497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19174497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19174497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19174497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19174497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19174497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19174497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19174497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19174497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19174497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19174497pubmed:statusMEDLINElld:pubmed
pubmed-article:19174497pubmed:monthAprlld:pubmed
pubmed-article:19174497pubmed:issn1945-7197lld:pubmed
pubmed-article:19174497pubmed:authorpubmed-author:AhrénBoBlld:pubmed
pubmed-article:19174497pubmed:authorpubmed-author:NilssonPeter...lld:pubmed
pubmed-article:19174497pubmed:authorpubmed-author:DunningBeth...lld:pubmed
pubmed-article:19174497pubmed:authorpubmed-author:FoleyJames...lld:pubmed
pubmed-article:19174497pubmed:authorpubmed-author:SchweizerAnja...lld:pubmed
pubmed-article:19174497pubmed:authorpubmed-author:DejagerSylvie...lld:pubmed
pubmed-article:19174497pubmed:authorpubmed-author:PerssonMargar...lld:pubmed
pubmed-article:19174497pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19174497pubmed:volume94lld:pubmed
pubmed-article:19174497pubmed:ownerNLMlld:pubmed
pubmed-article:19174497pubmed:authorsCompleteYlld:pubmed
pubmed-article:19174497pubmed:pagination1236-43lld:pubmed
pubmed-article:19174497pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:meshHeadingpubmed-meshheading:19174497...lld:pubmed
pubmed-article:19174497pubmed:year2009lld:pubmed
pubmed-article:19174497pubmed:articleTitleVildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes.lld:pubmed
pubmed-article:19174497pubmed:affiliationDepartment of Clinical Sciences, Lund University, Lund, Sweden. bo.ahren@med.lu.selld:pubmed
pubmed-article:19174497pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19174497pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19174497lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19174497lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19174497lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19174497lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19174497lld:pubmed